ストックスクリーナーアプリを入手
3.525
2.62%
0.095
前日終値:
$3.43
開ける：
$3.4
24時間の取引高:
292.54K
Relative Volume:
0.16
時価総額：
$1.00B
収益：
-
当期純損益:
$-125.04M
株価収益率:
-4.2988
EPS:
-0.82
ネットキャッシュフロー:
$-122.99M
1週間 パフォーマンス:
+6.67%
1か月 パフォーマンス:
+36.43%
6か月 パフォーマンス:
+150.53%
1年 パフォーマンス:
+34.35%
1日の値動き範囲:
$3.3401
$3.62
1週間の範囲:
$3.15
$3.80
52週間の値動き範囲:
$1.01
$3.80
Erasca Inc Stock (ERAS) Company Profile
ERAS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ERAS
Erasca Inc
|
3.525 | 973.13M | 0 | -125.04M | -122.99M | -0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.25 | 115.62B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
744.62 | 79.10B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
847.66 | 52.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.11 | 51.72B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
200.33 | 42.00B | 447.02M | -1.18B | -906.14M | -6.1812 |
Erasca Inc Stock (ERAS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-16 | 開始されました | Stifel | Buy |
| 2025-09-03 | ダウングレード | BofA Securities | Buy → Underperform |
| 2025-08-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-26 | 開始されました | Raymond James | Outperform |
| 2024-11-18 | 開始されました | Jefferies | Buy |
| 2024-03-11 | 開始されました | CapitalOne | Overweight |
| 2024-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-10-11 | 開始されました | H.C. Wainwright | Buy |
| 2023-03-30 | 開始されました | Mizuho | Buy |
| 2023-02-24 | 開始されました | Goldman | Buy |
| 2023-02-03 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
すべてを表示
Erasca Inc (ERAS) 最新ニュース
Erasca (ERAS) Valuation Check After ERAS-0015 Patent Extension and New Chief Scientific Officer Appointment - simplywall.st
Erasca Inc stock hits 52-week high at $3.68 By Investing.com - Investing.com Nigeria
Erasca Inc stock hits 52-week high at $3.68 - Investing.com
Erasca (ERAS) Extends ERAS-0015 Patent to 2043 and Strengthens RAS Pipeline Momentum - simplywall.st
Discovering Opportunities: AirJoule Technologies Among 3 Promising Penny Stocks - simplywall.st
Aug Breakouts: Is Erasca Inc stock a buy for dividend growthEarnings Growth Report & AI Optimized Trading Strategy Guides - moha.gov.vn
Platform Technologies Drive $211B Surge in Precision Cancer Treatment - marketscreener.com
Mizuho Maintains Erasca (ERAS) Outperform Recommendation - Nasdaq
Check Out Erasca Inc (ERAS)’s Trade Data Rather Than the Analysts’ Views - Setenews
Mizuho raises Erasca stock price target to $5 on RAS space optimism - Investing.com Canada
Erasca price target raised to $5 from $4 at Mizuho - TipRanks
Erasca, Inc. (NASDAQ:ERAS) Given Average Rating of "Hold" by Analysts - MarketBeat
Affinity Asset Advisors LLC Grows Stock Holdings in Erasca, Inc. $ERAS - Defense World
Will Erasca Inc. stock outperform international peers2025 Top Gainers & Fast Gaining Stock Reports - Newser
Gitlab, Acadia Healthcare, Box And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Sahm
Analyst Confidence High in Erasca (ERAS) Amid Pipeline Advancement and Earlier Q3 2025 Results - Insider Monkey
Moving Averages: Why Erasca Inc. stock could be next big winnerInsider Buying & Momentum Based Trading Signals - moha.gov.vn
Unusually active option classes on open October 8th - MSN
Erasca to Present at the 8th Annual Evercore Healthcare Conference - The Manila Times
Adversity is less terrifying than hope: Erasca Inc (ERAS) - Setenews
Understanding Erasca Inc.’s price movementPortfolio Risk Summary & High Yield Equity Trading Tips - newser.com
Will Erasca Inc. stock benefit from automation2025 Earnings Surprises & Real-Time Volume Trigger Notifications - newser.com
Erasca Inc. stock chart pattern explainedJuly 2025 Market Mood & Safe Swing Trade Setups - newser.com
Why Erasca Inc. stock remains on watchlistsWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B - GlobeNewswire
ErascaTargeting Cancer's Most Commonly Mutated Pathway - RTTNews
Analyzing Precision BioSciences (NASDAQ:DTIL) and Erasca (NASDAQ:ERAS) - Defense World
HC Wainwright Issues Optimistic Estimate for Erasca Earnings - Defense World
Heatmap analysis for Erasca Inc. and competitorsEarnings Overview Summary & Short-Term Swing Trade Alerts - newser.com
Analyzing net buyer seller activity in Erasca Inc.July 2025 Gainers & Free Growth Oriented Trading Recommendations - newser.com
Using fundamentals and technicals on Erasca Inc.IPO Watch & Risk Managed Investment Signals - newser.com
HC Wainwright Comments on Erasca’s Q1 Earnings (NASDAQ:ERAS) - Defense World
Why Erasca Inc. stock could see breakout soonTrade Performance Summary & AI Optimized Trade Strategies - newser.com
Erasca Inc (ERAS) 財務データ
収益
当期純利益
現金流量
EPS
0.42%
0.32%
大文字化:
|
ボリューム (24 時間):